goldman sachs

With a market value of about $460 billion, Apple was worth more than Google, Goldman Sachs, General Motors, Ford, Starbucks and Boeing combined.

UPGRADES BofA/Merrill Lynch upgrades FedEx (NYSE: FDX) from Neutral to Buy.

ThinkEquity lifts Nuance Communications (Nasdaq: NUAN) from Hold to Buy. Piper Jaffray boosts Corning (NYSE: GLW) from Neutral to Overweight, raising its price target from $13 to $16.

Pacific Crest ups Riverbed Technology (Nasdaq: RVBD) from Sector Perform to Outperform, moving its price target to $34.

Sterne Agee upgrades K-Swiss (Nasdaq: KSWS) from Underperform to Neutral.

UPGRADES JPMorgan upgrades Dell (Nasdaq: DELL) from Underweight to Overweight with a price target of $21 (up from $17).

Stifel Nicolaus lifts GMX Resources (NYSE: GMXR) from Sell to Hold. Barclays boosts Seagate Technology (Nasdaq: STX) from Equalweight to Overweight, its price target raised from $21 to $31.

JPMorgan raises Franklin Resources (NYSE: BEN) from Underweight to Neutral, its price target boosted from $91 to $108.

UPGRADES Goldman Sachs upgrades CF Industries (NYSE: CF) to Conviction Buy with a price target of $225. Click Here for more color.

BofA/Merrill Lynch lifts CEMEX (NYSE: CX) from Neutral to Buy. Needham & Company boosts Under Armour, Inc. (NYSE: UA) from Hold to Buy, with an $86 price target.

UPGRADES Goldman Sachs upgrades Citi (NYSE: C) from Neutral to Buy with a price target of $36 (up from $35). Click Here for more color.

Piper Jaffray lifts Zimmer Holdings (NYSE: ZMH) from Neutral to Overweight, price target raised from $65 to $75.

UPGRADES Deutsche Bank upgrades Bed Bath and Beyond (Nasdaq: BBBY) to Buy with a price target of $70. Click Here for more color.

Citi lifts Novellus (Nasdaq: NVLS) from Neutral to Buy. Citi upgraded KLA-Tencor (Nasdaq: KLAC) from Neutral to Buy.

With firms like Goldman Sachs and Morgan Stanley reporting weak results, Wall Street’s moneymakers are doubting they will ever get back to their high-rolling ways.

UPGRADES Tesla (Nasdaq: TSLA) was upgraded by two firms Tuesday:

• Goldman Sachs from Neutral to Buy with a price target of $35.

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High:

• Idenix Pharmaceuticals, Inc.
  
  (Nasdaq: IDIX) high of $10.39. Idenix up about 47 percent to its new 52-week high Monday, following the announced acquisition of Inhibitex (Nasdaq: INHX) by Bristol-Myers Squibb over the weekend, as well as the Phase I initiation of NSSA inhibitor IDX719.
• Apple Inc.
  
  (Nasdaq: AAPL) high of $427.75.

UPGRADES Wedbush upgrades Exide Technologies (Nasdaq: XIDE) from Neutral to Outperform with a price target of $5. Click Here for more color.

Macquarie lowers J.C. Penney (NYSE: JCP) from Neutral to Outperform with a price target of $42.